Yuxin Shu

709 total citations
9 papers, 553 citations indexed

About

Yuxin Shu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yuxin Shu has authored 9 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Yuxin Shu's work include Immune cells in cancer (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yuxin Shu is often cited by papers focused on Immune cells in cancer (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yuxin Shu collaborates with scholars based in China, United States and Taiwan. Yuxin Shu's co-authors include Pingping Shen, Owais Ahmad, Nan Cheng, Nan Cheng, Nanfei Yang, Jianguo Ji, Wenlong Zhang, Zhiyuan Niu, Yonghua Cui and Yuanyuan Zhu and has published in prestigious journals such as Nature Communications, Biochemical Pharmacology and Experimental Cell Research.

In The Last Decade

Yuxin Shu

9 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuxin Shu China 9 254 244 151 142 46 9 553
Ahmed Sadik Germany 9 211 0.8× 116 0.5× 74 0.5× 73 0.5× 39 0.8× 11 420
Natarajan Mohan United States 6 259 1.0× 117 0.5× 144 1.0× 67 0.5× 51 1.1× 9 557
Tangming Peng China 13 244 1.0× 66 0.3× 123 0.8× 64 0.5× 17 0.4× 17 436
Haixia Zhao China 13 285 1.1× 98 0.4× 64 0.4× 88 0.6× 18 0.4× 26 545
Junli Liu China 14 201 0.8× 78 0.3× 71 0.5× 94 0.7× 63 1.4× 31 594
Mirja Tamara Prentzell Germany 9 482 1.9× 68 0.3× 60 0.4× 61 0.4× 36 0.8× 10 674
Hongyun Zheng China 14 213 0.8× 60 0.2× 111 0.7× 43 0.3× 37 0.8× 24 451
Diana Boriero Italy 8 187 0.7× 87 0.4× 120 0.8× 141 1.0× 89 1.9× 10 496

Countries citing papers authored by Yuxin Shu

Since Specialization
Citations

This map shows the geographic impact of Yuxin Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxin Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxin Shu more than expected).

Fields of papers citing papers by Yuxin Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxin Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxin Shu. The network helps show where Yuxin Shu may publish in the future.

Co-authorship network of co-authors of Yuxin Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxin Shu. A scholar is included among the top collaborators of Yuxin Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxin Shu. Yuxin Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bei, Yuncheng, Nan Cheng, Ting Chen, et al.. (2020). CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy. Advanced Science. 7(22). 2001417–2001417. 38 indexed citations
2.
Cheng, Nan, et al.. (2020). Targeting tumor-associated macrophages as an antitumor strategy. Biochemical Pharmacology. 183. 114354–114354. 128 indexed citations
3.
Cheng, Nan, Yuncheng Bei, Yue Song, et al.. (2020). B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy. Biochemical Pharmacology. 183. 114298–114298. 54 indexed citations
5.
Niu, Zhiyuan, Qian Shi, Wenlong Zhang, et al.. (2017). Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs. Nature Communications. 8(1). 158 indexed citations
6.
Shu, Yuxin, Yan Lu, Wei Zheng, et al.. (2016). Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4. Oncotarget. 7(47). 76984–76994. 31 indexed citations
7.
Che, Yi, Zhou Zhu, Yuxin Shu, et al.. (2014). Chronic unpredictable stress impairs endogenous antioxidant defense in rat brain. Neuroscience Letters. 584. 208–213. 74 indexed citations
8.
Shu, Yuxin, Zhiyuan Niu, Wei Zheng, et al.. (2014). PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cells. Experimental Cell Research. 322(1). 30–38. 8 indexed citations
9.
Cui, Yonghua, Yuxin Shu, Yuanyuan Zhu, Yonghui Shi, & Guowei Le. (2012). High-Fat Diets Impair Spatial Learning of Mice in the Y-Maze Paradigm: Ameliorative Potential of α-Lipoic Acid. Journal of Medicinal Food. 15(8). 713–717. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026